MMWR Morb Mortal Wkly Rep. 2008 May 9;57(18):489-94.
In 1988, the World Health Assembly resolved to eradicate poliomyelitis. Subsequently, the Global Polio Eradication Initiative reduced the global incidence of polio associated with wild polioviruses (WPVs) from an estimated 350,000 cases in 1988 to 1,997 reported cases in 2006 and reduced the number of countries that have never succeeded in interrupting WPV transmission from 125 to four (Afghanistan, India, Nigeria, and Pakistan). Type 2 WPV (WPV2) circulation was last observed in October 1999. In February 2007, the World Health Organization (WHO) convened a stakeholders meeting to agree on an accelerated polio-eradication effort to be used during 2007-2008 and establish milestones to monitor progress. Programmatic strategies implemented in 2007 included expanded use of type 1 monovalent oral poliovirus vaccine (OPV) (mOPV1) to eliminate type 1 WPV (WPV1) transmission before type 3 WPV (WPV3) and targeted use of type 3 monovalent OPV (mOPV3) in selected areas. This report summarizes these strategies and overall progress toward reaching the milestones, including a decline in the overall number of WPV cases to 1,310 in 2007 and substantial progress toward interruption of WPV1 circulation in India in 2008.
1988年,世界卫生大会决定根除脊髓灰质炎。随后,全球根除脊髓灰质炎行动将与野生脊髓灰质炎病毒(WPV)相关的脊髓灰质炎全球发病率从1988年估计的35万例降至2006年报告的1997例,并将从未成功阻断WPV传播的国家数量从125个减少到4个(阿富汗、印度、尼日利亚和巴基斯坦)。最后一次观察到2型WPV(WPV2)传播是在1999年10月。2007年2月,世界卫生组织(WHO)召开了一次利益相关者会议,商定在2007 - 2008年期间加快脊髓灰质炎根除工作,并确定监测进展的里程碑。2007年实施的规划策略包括扩大使用1型单价口服脊髓灰质炎疫苗(mOPV1),以便在3型WPV(WPV3)之前消除1型WPV(WPV1)传播,并在选定地区有针对性地使用3型单价OPV(mOPV3)。本报告总结了这些策略以及实现里程碑的总体进展,包括2007年WPV病例总数降至1310例,以及2008年在印度阻断WPV1传播方面取得的重大进展。